Heding 1984.
Methods | Trial design: Parallel design Randomisation procedure: Data missing Allocation concealment: Unclear Blinding: Double‐blind | |
Participants | Country: Denmark Setting: Multi centre Number: 67/68 human/animal insulin Type of diabetes: Newly diagnosed type 1 diabetic children Mean age [years]: 37/33 human/animal insulin Mean diabetes duration [years]: 15/14 human/animal insulin Other characteristics: | |
Interventions | Type of human insulin: Semi‐synthetic Type of animal insulin: Purified porcine Duration of trial [months]: 12 | |
Outcomes | 1.HbA1c [%]: ‐ 2.HbA1 [%]: ‐ 3.Fasting plasma glucose [mmol/L] ‐ 4.Insulin dose [Units/day]: ‐ 5.Insulin antibodies [%]: 44 vs 59 (hum. vs anim.) 6.Adverse effects: ‐ | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |